WebSep 3, 2024 · Chemotherapy-induced peripheral neuropathy (CIPN) is a major adverse effect of various chemotherapeutic drugs for cancer. 1 Platinum agents, especially cisplatin, are an important group of chemotherapeutic drugs. They are used in the management of various cancers with curative and/or palliative intent. WebMay 20, 2024 · We report a systematic review and meta-analysis of research using animal models of chemotherapy-induced peripheral neuropathy (CIPN). We systematically searched 5 online databases in September 2012 and updated the search in November 2015 using machine learning and text mining to reduce the screening for inclusion workload …
Nutrients Free Full-Text Non-Pharmacological Self-Management ...
WebJul 22, 2024 · Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect caused by a spectrum of classes of widely used anticancer therapeutics including platinum-based agents, microtubule disruptors (taxanes and vinca alkaloids), proteasome, and angiogenesis inhibitors ( Table 2 ). 17 – 26 Peripheral nervous system damage has also … WebMar 19, 2014 · This review paper intends to put together and discuss the spectrum of chemotherapy-induced peripheral neuropathy (CIPN) characteristics so as to highlight areas of future research to pursue on the topic. Current knowledge shows that the pathogenesis of CIPN still remains elusive, mostly because there are several sites of involvement in the ... grain exporting countries
A systematic summary and comparison of animal models …
WebLooking for online definition of CIPN or what CIPN stands for? CIPN is listed in the World's largest and most authoritative dictionary database of abbreviations and acronyms. CIPN … WebFeb 8, 2024 · Chemotherapy- induced peripheral neuropathy (CIPN) is one of the major dose-limiting side effects of many chemotherapeutic agents including platinum analogues, vinca alkaloids, and taxanes [].The structure and function of peripheral motor, sensory and autonomic neurons are affected, causing peripheral neuropathic signs and symptoms … WebA systematic review and meta-analysis involving 4,179 patients revealed a CIPN prevalence of 68% in the first month after chemotherapy, 60% within three months, and 30% within six months or longer, with prevalence associated with … grain export from ukraine